Ignite Creation Date:
2025-12-24 @ 10:07 PM
Ignite Modification Date:
2026-02-24 @ 3:16 PM
Study NCT ID:
NCT02819635
Status:
COMPLETED
Last Update Posted:
2022-06-30
First Post:
2016-06-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-09-26
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-12-13
Completion Date Type:
ACTUAL
First Submit Date:
2016-06-28
First Submit QC Date:
None
Study First Post Date:
2016-06-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-06-03
Results First Submit QC Date:
None
Results First Post Date:
2022-06-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-06-03
Last Update Post Date:
2022-06-30
Last Update Post Date Type:
ACTUAL